X4 Pharmaceuticals Ownership | Who Owns X4 Pharmaceuticals?
X4 Pharmaceuticals Ownership Summary
X4 Pharmaceuticals is owned by 0.02% institutional investors, 1.29% insiders, and 98.69% retail investors. Blackrock is the largest institutional shareholder, holding 5.34% of XFOR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.90% of its assets in X4 Pharmaceuticals shares.
XFOR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | X4 Pharmaceuticals | 0.02% | 1.29% | 98.69% |
| Sector | Healthcare Stocks | 218.58% | 11.00% | -129.58% |
| Industry | Biotech Stocks | 296.15% | 10.91% | -207.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 10.68M | 5.34% | $6.19M |
| Susquehanna group, llp | 1.89M | 0.94% | $1.38M |
| Goldman sachs group | 477.64K | 0.24% | $350.39K |
| Millennium management | 258.76K | 0.13% | $189.83K |
| Morgan stanley | 229.34K | 0.11% | $133.01K |
| Alliancebernstein | 109.57K | 0.05% | $80.38K |
| Bank of america corp /de/ | 90.96K | 0.05% | $52.76K |
| Wolverine trading | 39.66K | 0.02% | $32.05K |
| Bnp paribas arbitrage, snc | 29.30K | 0.01% | $21.50K |
| Aqr capital management | 26.84K | 0.01% | $19.69K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nea management company | 499.56K | 0.07% | $949.16K |
| Cassady schiller wealth management | 20.00K | 0.01% | $14.67K |
| Ica group wealth management | 6.40K | 0.00% | $3.71K |
| Susquehanna group, llp | 1.89M | 0.00% | $1.38M |
| Goldman sachs group | 477.64K | 0.00% | $350.39K |
| Srs capital advisors | 1.12K | 0.00% | $2.13K |
| Millennium management | 258.76K | 0.00% | $189.83K |
| Blackrock | 10.68M | 0.00% | $6.19M |
| Legal & general group | - | - | - |
| Frazier financial advisors | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 10.68M | 0.00% | 1.94M |
| Susquehanna group, llp | 1.89M | 0.00% | 1.71M |
| Goldman sachs group | 477.64K | 0.00% | 185.05K |
| Wolverine trading | 39.66K | - | 39.66K |
| Ica group wealth management | 6.40K | 0.00% | 3.65K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bain capital life sciences investors | - | - | -16.92M |
| Nea management company | 499.56K | 0.07% | -14.49M |
| Blackrock funding, inc. /de | - | - | -11.43M |
| Vanguard group | - | - | -8.07M |
| Kingdon capital management | - | - | -7.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wolverine trading | 39.66K | - | 39.66K | $32.05K |
| Russell investments group | 1.90K | - | 1.90K | $1.10K |
| Srs capital advisors | 1.12K | 0.00% | 1.12K | $2.13K |
| Raymond james financial | 66.00 | - | 66.00 | $125.00 |
| Clearstead advisors | 64.00 | - | 64.00 | $122.00 |
Sold Out
| Holder | Change |
|---|---|
| Frazier financial advisors | -10.00 |
| Headlands | -16.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Sterling capital management | -172.00 |
| Highmark wealth management | -180.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 32 | -66.67% | 1,495,756 | -98.48% | - | 1028.22% | 8 | -80.95% | 23 | -4.17% |
| Mar 31, 2025 | 96 | 1.05% | 98,519,817 | -1.31% | 1 | 0.06% | 42 | 10.53% | 24 | 9.09% |
| Dec 31, 2024 | 51 | -50.00% | 29,200,759 | -70.97% | 14 | 0.58% | 18 | -61.70% | 12 | -36.84% |
| Sep 30, 2024 | 102 | -2.86% | 100,589,648 | -0.93% | 50 | 1.94% | 47 | -16.07% | 19 | 5.56% |
| Jun 30, 2024 | 105 | 1.94% | 101,538,962 | -1.42% | 50 | 1.51% | 56 | 43.59% | 18 | -28.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 5.03M | 2.90% | 1.00 |
| Vanguard Total Stock Mkt Idx Inv | 159.10K | 2.22% | - |
| iShares Russell 2000 ETF | 84.03K | 1.17% | -14.31K |
| MEDICAL BioHealth EUR Acc | 1.78M | 1.06% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 64.53K | 0.90% | - |
| Fidelity Small Cap Index | 60.83K | 0.85% | 4.08K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.00M | 0.58% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 1.00M | 0.58% | - |
| A4Investments SICAV SIF ACCI IlanaA2EURH | 35.00K | 0.49% | 35.00K |
| Vanguard Russell 2000 ETF | 28.05K | 0.39% | -9.34K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Baldry Mark | Chief Commercial Officer | Buy | $2.56K |
| May 17, 2024 | Baldry Mark | Chief Commercial Officer | Buy | $14.65K |
| Nov 15, 2024 | Baldry Mark | Chief Commercial Officer | Buy | $4.60K |
| Jan 24, 2025 | Ragan Paula | President and CEO | Sell | $34.72K |
| Jan 24, 2025 | Mostafa Adam S. | Chief Financial Officer | Sell | $33.95K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 5 |
| 2024 Q4 | 1 | 7 |
| 2024 Q3 | - | 1 |
XFOR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools